🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06670560
Active, not recruiting Observational

Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine

NCT06670560 · tracked via the Priya Life Science China tracker
Sponsor
Zhou Chengzhi
Phase
Observational
Started
2024-09-05
Last updated
2024-11-07

Condition(s) studied

RespiratoryEpidemiologyNeoplasms

Study summary

The purpose of this observational study is to understand the changes in the types of respiratory patients hospitalized in China in recent years through a multicenter retrospective clinical study, and at the same time to understand the reasons for hospitalization and the distribution of different tumor types in oncology patients, so as to provide data support and theoretical basis for the future development of China's respiratory department.

The main questions it aims to answer are

1. the trend of change of respiratory diseases in China in the past 10 years.
2. the trend of change in the causes of hospitalization of respiratory tumor patients in China in the past 10 years.
3. the trend of the proportion of each tumor in the respiratory department in China over the past 10 years.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: Clinical diagnosis of Respiratory diseases Must be an inpatient Exclusion Criteria: Non-respiratory inpatients

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chengzhi Zhou Guangdong Guangzhou

More Zhou Chengzhi trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06670560 on ClinicalTrials.gov ↗ ← All trials in China